Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Adolfsson

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Nature Clinical Practice. Urology|October 13, 2006
Individualized assessment of prostate cancer riskJan Adolfsson
Acta Oncologica (Stockholm, Sweden)|April 20, 2010
Screening for prostate cancer - will we ever know?Jan Adolfsson
European Urology|March 18, 2008
Editorial comment on: predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillanceJan Adolfsson
European Urology|April 15, 2008
The management of category T1a-T1b (incidental) prostate cancer: can we predict who needs treatment?Jan Adolfsson
International Journal of Epidemiology|April 19, 2007
Commentary: on the incidence of histological prostate cancer and the probable diagnosis of cases with tumours too small to produce symptoms or to attract attention on physical examination--the findings of Dr Arnold Rice RichJan Adolfsson
BJU International|April 22, 2008
Watchful waiting and active surveillance: the current positionJan Adolfsson
Pharmacoeconomics|February 26, 2003
Health-related quality-of-life assessments in patients with advanced cancer of the prostateJan Adolfsson
European Urology|February 10, 2009
Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancerJan Adolfsson
Scandinavian Journal of Urology|May 23, 2022
Citing and endpointsJan Adolfsson
Nature Clinical Practice. Urology|May 2, 2007
Can we define which patients with prostate cancer are suitable for expectant management?Jan Adolfsson
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Nature Clinical Practice. Urology|October 13, 2006
Individualized assessment of prostate cancer riskJan Adolfsson
Acta Oncologica (Stockholm, Sweden)|April 20, 2010
Screening for prostate cancer - will we ever know?Jan Adolfsson
European Urology|March 18, 2008
Editorial comment on: predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillanceJan Adolfsson
European Urology|April 15, 2008
The management of category T1a-T1b (incidental) prostate cancer: can we predict who needs treatment?Jan Adolfsson
International Journal of Epidemiology|April 19, 2007
Commentary: on the incidence of histological prostate cancer and the probable diagnosis of cases with tumours too small to produce symptoms or to attract attention on physical examination--the findings of Dr Arnold Rice RichJan Adolfsson
BJU International|April 22, 2008
Watchful waiting and active surveillance: the current positionJan Adolfsson
Pharmacoeconomics|February 26, 2003
Health-related quality-of-life assessments in patients with advanced cancer of the prostateJan Adolfsson
European Urology|February 10, 2009
Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancerJan Adolfsson
Scandinavian Journal of Urology|May 23, 2022
Citing and endpointsJan Adolfsson
Nature Clinical Practice. Urology|May 2, 2007
Can we define which patients with prostate cancer are suitable for expectant management?Jan Adolfsson
Pageof 17